Department of Anesthesiology, Reanimation and Intensive Care, Gregorio Marañón University General Hospital, 28007 Madrid, Spain.
Department of Physiology, Faculty of Medicine, Autónoma University, 28029 Madrid, Spain.
Biomed Res Int. 2014;2014:531087. doi: 10.1155/2014/531087. Epub 2014 Mar 26.
The aim of this study was to assess the effects of short-term esmolol therapy on coronary artery structure and function and plasma oxidative stress in spontaneously hypertensive rats (SHR). For this purpose, 14-month-old male SHR were treated for 48 hours with esmolol (SHR-E, 300 μ g/kg/min). Age-matched untreated male SHR and Wistar Kyoto rats (WKY) were used as hypertensive and normotensive controls, respectively. At the end of intervention we performed a histological study to analyze coronary artery wall width (WW), wall-to-lumen ratio (W/L), and media cross-sectional area (MCSA). Dose-response curves for acetylcholine (ACh) and sodium nitroprusside were constructed. We also assessed several plasma oxidative stress biomarkers, namely, superoxide scavenging activity (SOSA), nitrites, and total antioxidant capacity (TAC). We observed a significant reduction in WW (P < 0.001), W/L (P < 0.05), and MCSA (P < 0.01) and improved endothelium-dependent relaxation (AUC(SHR-E) = 201.2 ± 33 versus AUC(SHR) = 97.5 ± 21, P < 0.05) in SHR-E compared with untreated SHR; no differences were observed for WW, MCSA, and endothelium-dependent relaxation by ACh at higher concentrations (10(-6) to 10(-4) mol/l) for SHR-E with respect to WKY. SOSA (P < 0.001) and nitrite (P < 0.01) values were significantly higher in SHR-E than in untreated SHR; however, TAC did not increase after treatment with esmolol. Esmolol improves early coronary artery remodeling in SHR.
本研究旨在评估短期艾司洛尔治疗对自发性高血压大鼠(SHR)冠状动脉结构和功能以及血浆氧化应激的影响。为此,14 月龄雄性 SHR 接受艾司洛尔(SHR-E,300 μ g/kg/min)治疗 48 小时。年龄匹配的未治疗雄性 SHR 和 Wistar Kyoto 大鼠(WKY)分别作为高血压和正常血压对照。在干预结束时,我们进行了组织学研究,以分析冠状动脉壁宽度(WW)、壁腔比(W/L)和中膜横截面积(MCSA)。构建了乙酰胆碱(ACh)和硝普钠的剂量-反应曲线。我们还评估了几种血浆氧化应激生物标志物,即超氧化物清除活性(SOSA)、亚硝酸盐和总抗氧化能力(TAC)。我们观察到 WW(P < 0.001)、W/L(P < 0.05)和 MCSA(P < 0.01)显著降低,以及 SHR-E 中内皮依赖性舒张(AUC(SHR-E)= 201.2 ± 33 比 AUC(SHR)= 97.5 ± 21,P < 0.05)改善;在 SHR-E 中,用 ACh 在较高浓度(10(-6)至 10(-4)mol/l)测量时,WW、MCSA 和内皮依赖性舒张无差异与 WKY 相比。与未治疗的 SHR 相比,SHR-E 中的 SOSA(P < 0.001)和亚硝酸盐(P < 0.01)值显著升高;然而,在用艾司洛尔治疗后,TAC 没有增加。艾司洛尔可改善 SHR 的早期冠状动脉重塑。